News
NAGE
3.860
+0.52%
0.020
Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)
TipRanks · 1d ago
Weekly Report: what happened at NAGE last week (0518-0522)?
Weekly Report · 4d ago
NATIONAL ADVERTISING REVIEW BOARD RECOMMENDS NIAGEN MODIFY OR DISCONTINUE CERTAIN TRU NIAGEN NAD+ DIETARY SUPPLEMENT CLAIMS
Reuters · 05/21 14:31
Niagen Bioscience Earnings Call Highlights Growth Push
TipRanks · 05/20 05:40
Weekly Report: what happened at NAGE last week (0511-0515)?
Weekly Report · 05/18 09:22
Niagen Bioscience Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/11 11:15
Niagen Bioscience Price Target Cut to $11.00/Share From $12.00 by HC Wainwright & Co.
Dow Jones · 05/11 11:15
HC Wainwright & Co. Maintains Buy on Niagen Bioscience, Lowers Price Target to $11
Benzinga · 05/11 11:06
Niagen Bioscience price target lowered to $11 from $12 at H.C. Wainwright
TipRanks · 05/11 10:46
NIAGEN BIOSCIENCE, INC. <NAGE.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $11 FROM $12
Reuters · 05/11 10:02
Weekly Report: what happened at NAGE last week (0504-0508)?
Weekly Report · 05/11 09:21
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Reuters · 05/11 07:27
Niagen Bioscience to attend Sohn Investment Conference Emerging Company Pavilion
PUBT · 05/08 12:32
Niagen Bioscience price target lowered to $12 from $13 at Roth Capital
TipRanks · 05/07 20:07
Niagen Bioscience (NAGE) Receives a Buy from Ladenburg Thalmann & Co.
TipRanks · 05/07 13:48
Analysts Offer Insights on Healthcare Companies: Medline (MDLN), Niagen Bioscience (NAGE) and BeOne Medicines (ONC)
TipRanks · 05/07 12:43
Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga · 05/07 12:04
Niagen Bioscience reports Q1 EPS 7c, consensus 6c
TipRanks · 05/07 01:51
Niagen Bioscience sees 2026 sales growth 10%-15%
TipRanks · 05/07 01:50
Niagen Bioscience Earnings Call Highlights Growth Push
TipRanks · 05/07 01:11
More
Webull provides a variety of real-time NAGE stock news. You can receive the latest news about Niagen Bioscience, Inc through multiple platforms. This information may help you make smarter investment decisions.
About NAGE
Niagen Bioscience, Inc. is a global bioscience company dedicated to promoting healthy aging. Its segments include Consumer Products, Ingredients segment, Analytical Reference Standards and Services and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors. The ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and outsourcing facilities. The Analytical Reference Standards and Services segment offer the supply of phytochemical reference standards and other research and development services. The Pharmaceutical segment focuses on the pharmaceutical development of its nicotinamide adenine dinucleotide (NAD) precursor portfolio for potential therapeutic applications in rare diseases.